The polymorphism L204F affects transport and membrane expression of the sodium-dependent organic anion transporter SOAT (SLC10A6)

Author(s):  
Katharina Bakhaus ◽  
Daniela Fietz ◽  
Sabine Kliesch ◽  
Wolfgang Weidner ◽  
Martin Bergmann ◽  
...  
2007 ◽  
Vol 282 (27) ◽  
pp. 19728-19741 ◽  
Author(s):  
Joachim Geyer ◽  
Barbara Döring ◽  
Kerstin Meerkamp ◽  
Bernhard Ugele ◽  
Nadiya Bakhiya ◽  
...  

Author(s):  
Gary Grosser ◽  
Josefine Bennien ◽  
Alberto Sánchez-Guijo ◽  
Katharina Bakhaus ◽  
Barbara Döring ◽  
...  

2004 ◽  
Vol 384 (1) ◽  
pp. 87-92 ◽  
Author(s):  
Fanfan ZHOU ◽  
Zui PAN ◽  
Jianjie MA ◽  
Guofeng YOU

Human organic anion transporter 4 (hOAT4) belongs to a family of organic anion transporters which play critical roles in the body disposition of clinically important drugs, including anti-HIV therapeutics, antitumour drugs, antibiotics, anti-hypertensives and anti-inflammatories. hOAT4-mediated transport of the organic anion oestrone sulphate in COS-7 cells was inhibited by the histidine-modifying reagent DEPC (diethyl pyrocarbonate). Therefore the role of histidine residues in the function of hOAT4 was examined by site-directed mutagenesis. All five histidine residues of hOAT4 were converted into alanine, singly or in combination. Single replacement of His-47, or simultaneous replacement of His-47/52/83 or His-47/52/83/305/469 (H-less) led to a 50–80% decrease in transport activity. The decreased transport activity of these mutants was correlated with a decreased amount of cell-surface expression, although the total cell expression of these mutants was similar to that of wild-type hOAT4. These results suggest that mutation at positions 47, 47/52/83 and 47/52/83/305/469 impaired membrane expression rather than function. We also showed that, although most of the histidine mutants of hOAT4 were sensitive to inhibition by DEPC, H469A (His-469→Ala) was completely insensitive to inhibition by this reagent. Therefore modification of His-469 is responsible for the inhibition of hOAT4 by DEPC.


2009 ◽  
Vol 297 (1) ◽  
pp. F71-F79 ◽  
Author(s):  
Masanori Nakakariya ◽  
Yoichiro Shima ◽  
Yoshiyuki Shirasaka ◽  
Keisuke Mitsuoka ◽  
Takeo Nakanishi ◽  
...  

Because citrulline plasma concentration is elevated in kidney failure, citrulline could be a biomarker of renal insufficiency, although the mechanism regulating its disposition in the kidney has not been clarified. In rat kidney slices, citrulline uptake was apparently Na+ dependent, saturable with Km 556 μM, and significantly inhibited by anionic (PAH) and cationic (TEA) compounds, but not by probenecid at 1 mM. Preincubation of kidney slices with glutarate increased citrulline uptake, while such an increase was not observed after preincubation of the slices in Na+-free buffer. This result suggested that a sodium-dependent dicarboxylate cotransporter is involved in citrulline uptake by rat kidney slices. In studies using transporter-overexpressing cells, human organic anion transporter 1 (OAT1) and rat Oat1 exhibited citrulline transport activity with Km values of 238 and 373 μM, respectively, while other OATs and organic cation transporters (OCTs) did not transport citrulline. Based on the relative activity factor method, the contribution of rat Oat1 to the overall uptake of citrulline in rat kidney slices was ∼70%. Moreover, the interaction among citrulline, PAH, and probenecid uptakes via rat Oat1 suggested that there are multiple functional sites on Oat1 and that the citrulline site may be distinct from the PAH and probenecid site. Thus OAT1/Oat1 appears to be one of the major contributors to renal basolateral uptake of citrulline, and impaired activities of these transporters may contribute substantially to the increase in plasma citrulline in renal failure. Accordingly, citrulline may be useful for diagnosis of kidney function as is creatinine.


Author(s):  
Gary Grosser ◽  
Daniela Fietz ◽  
Sabine Günther ◽  
Katharina Bakhaus ◽  
Helene Schweigmann ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document